Fundamental dimension Equity attribute | MELIPeer $1,839.72▲+0.31% Cap $93.27BP/E 50.1x QuantScore58/100 | AMZNLeader $262.45▲+4.98% Cap $2.83TP/E 20.8x QuantScore71/100 | BABAPeer $99.64▼-2.14% Cap $247.9BP/E 21.5x QuantScore51/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
84/100 |
94/100 |
24/100 |
Valuation Multiples, PEG & DCF upside | 38/100 | 67/100 | 89/100 |
Health Piotroski, Altman Z, leverage & liquidity | 34/100 | 67/100 | 38/100 |
Growth Revenue / earnings growth & margins | 73/100 | 52/100 | 21/100 |
Sentiment Analyst ratings, targets & revisions | 59/100 | 73/100 | 81/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 50.1x | 20.8x | 21.5x |
Forward P/E (next FY) | 48.0x | 20.5x | 2.3x |
EV / EBITDA (TTM) | 30.3x | 11.7x | 11.4x |
Price / Sales | 2.7x | 3.6x | 1.6x |
Price / Free Cash Flow | 7.9x | -243.5x | -21.0x |
PEG ratio | -5.41 | 0.24 | -0.42 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 6 / 9 | 4 / 9 |
Altman Z-Score | 2.41 (Grey) | 4.67 (Safe) | 2.50 (Grey) |
Total debt / equity | 1.68 | 0.40 | 0.25 |
Quick ratio | 1.1x | 0.9x | 1.4x |
Interest coverage | 14.5x | 28.1x | 4.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +39.1% | +12.4% | +2.7% |
Net income growth YoY | +4.5% | +31.1% | -20.4% |
Gross margin (TTM) | 42.7% | 50.8% | 38.1% |
Operating margin (FY) | 11.1% | 11.2% | 5.8% |
FCF margin (FY) | 37.3% | 1.1% | -5.0% |
5. Trailing price performancePrice change over period |
1M return | +2.9% | +3.4% | -10.1% |
3M return | +1.4% | +6.2% | -12.6% |
6M return | -0.9% | +4.7% | -24.3% |
Year to date | -8.7% | +13.7% | -32.0% |
1Y return | -12.5% | +21.2% | -42.0% |
3Y return | +55.9% | +104.4% | +23.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $422.46 -77.0% premium | $48.00 -81.7% premium | $127.14 +27.6% upside |
Wall Street consensus target | $2,160.00 +17.4% · range $1,750.00–$2,450.00 | $328.90 +25.3% · range $200.00–$390.00 | $182.00 +82.7% · range $160.00–$209.00 |
Consensus stance | 73% Buy27% Hold-0% Sell | 89% Buy10% Hold1% Sell | 86% Buy12% Hold2% Sell |